Esperion Therapeutics, Inc.
GB ˙ LSE ˙ US29664W1053
3,13 USD ↓ -0,00 (-0,16%)
2026-06-05
PREȚUL ACȚIUNILOR
SecurityGB:0IIM / Esperion Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership261,760 shares
Latest Disclosed Value $ 968,512
Alliancebernstein L.p. ownership in 0IIM / Esperion Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 261,760 shares of Esperion Therapeutics, Inc. (GB:0IIM) valued at $711,490 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 261,760 shares of Esperion Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $819,309 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 261,760 0 0.00 969 0.00 0.0003
2026-02-17 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 261,760 50,000 23.61 969 72.55 0.0003
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 211,760 -68,000 -24.31 561 104.00 0.0002
2025-08-14 2025-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 279,760 120,500 75.66 275 20.09 0.0001
2025-05-15 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 159,260 0 0.00 229 -34.57 0.0001
2025-02-12 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 159,260 -22,850 -12.55 350 16.67 0.0001
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 182,110 0 0.00 300 -25.74 0.0001
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 182,110 182,110 404 0.0001
2023-08-15 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -73,000 -100.00 0 -100.00
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 73,000 18,400 33.70 116 -65.88 0.0000
2023-02-15 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 54,600 11,647 27.12 340 18.06 0.0002
2022-11-15 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 42,953 6,153 16.72 288 23.08 0.0001
2022-08-15 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 36,800 8,500 30.04 234 78.63 0.0001
2022-05-13 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 28,300 0 0.00 131 -7.75 0.0001
2022-02-14 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 28,300 -270 -0.95 142 -58.72 0.0001
2021-11-10 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 28,570 0 0.00 344 -43.05 0.0001
2021-07-30 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 28,570 4,800 20.19 604 -9.45 0.0002
2021-05-06 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 23,770 -6,300 -20.95 667 -14.71 0.0003
2021-02-08 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 30,070 0 0.00 782 -30.05 0.0004
2020-11-12 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 30,070 -6,200 -17.09 1,118 -39.92 0.0006
2020-08-13 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 36,270 3,300 10.01 1,861 78.94 0.0011
2020-05-14 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 32,970 0 0.00 1,040 -47.10 0.0007
2020-02-18 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 32,970 -29,494 -47.22 1,966 -14.15 0.0011
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 62,464 0 0.00 2,290 -21.20 0.0014
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 62,464 34,894 126.57 2,906 162.51 0.0018
2019-05-14 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 27,570 0 0.00 1,107 -12.70 0.0007
2019-02-13 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 27,570 -7,300 -20.93 1,268 -18.03 0.0009
2018-11-08 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 34,870 0 0.00 1,547 13.17 0.0010
2018-08-13 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 34,870 4,600 15.20 1,367 -37.55 0.0010
2018-05-14 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 30,270 -4,700 -13.44 2,189 -4.91 0.0016
2018-02-13 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 34,970 10,000 40.05 2,302 84.01 0.0016
2017-11-13 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 24,970 -5,100 -16.96 1,251 -10.13 0.0009
2017-08-10 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 30,070 1,500 5.25 1,392 37.96 0.0011
2017-05-11 2017-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 28,570 -2,700 -8.63 1,009 157.40 0.0008
2017-02-13 2016-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 31,270 0 0.00 392 -9.47 0.0003
2016-11-10 2016-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 31,270 0 0.00 433 40.13 0.0004
2016-08-11 2016-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 31,270 8,900 39.79 309 -18.25 0.0003
2016-05-13 2016-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 22,370 0 0.00 378 -24.10 0.0003
2016-02-16 2015-12-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 22,370 -1,400 -5.89 498 -11.23 0.0004
2016-02-12 2015-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 22,370 528
2015-11-13 2015-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 23,770 -30,920 -56.54 561 -87.45 0.0005
2015-08-14 2015-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 54,690 39,750 266.06 4,471 223.28 0.0037
2015-05-13 2015-03-31 13F ESPERION THERAPEUTICS COM 29664W105 14,940 -31,290 -67.68 1,383 -26.04 0.0011
2015-02-13 2014-12-31 13F ESPERION THERAPEUTICS COM 29664W105 46,230 -10,900 -19.08 1,870 33.86 0.0016
2014-11-13 2014-09-30 13F ESPERION THERAPEUTICS COM 29664W105 57,130 -300 -0.52 1,397 53.52 0.0012
2014-08-13 2014-06-30 13F ESPERION THERAPEUTICS COM 29664W105 57,430 502 0.88 910 5.69 0.0008
2014-05-13 2014-03-31 13F ESPERION THERAPEUTICS COM 29664W105 56,928 0 0.00 861 10.10 0.0007
2014-02-13 2013-12-31 13F ESPERION THERAPEUTICS COM 29664W105 56,928 56,830 57,989.80 782 39,000.00 0.0007
2013-11-14 2013-09-30 13F ESPERION THERAPEUTICS COM 29664W105 98 98 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.